chrisvoncsefalvay/vaers-outcomes huggingface dataset:
runny nose; dry heaves; Chills; nausea; very sick; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), ILLNESS (very sick), RHINORRHOEA (runny nose), RETCHING (dry heaves) and CHILLS (Chills) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 virus test positive in November 2020. Concomitant products included ALPRAZOLAM (XANAX), CITALOPRAM, LISINOPRIL, ATORVASTATIN and METFORMIN for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 23-Mar-2021, the patient experienced ILLNESS (very sick), CHILLS (Chills) and NAUSEA (nausea). On an unknown date, the patient experienced RHINORRHOEA (runny nose) and RETCHING (dry heaves). At the time of the report, PAIN IN EXTREMITY (sore arm), ILLNESS (very sick), RHINORRHOEA (runny nose), RETCHING (dry heaves), CHILLS (Chills) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       patient treatment information was not provided.
Dizziness, light-headedness, chills, aches, weakness, felt like a high fever but temp was 97.6-98.1
Pt still c/o soreness, tenderness on the injection site a month after the shot. There is still visible slight bruising.
01Feb, 01Mar, 17Apr91 pt vax;  exp minimal fatigue after 1st dose, mod to severe reaction after 2nd dose. After 3rd dose exp mild laryngitis, viral URI sx, clear mucous production, coughing & sneezing.see wm
Felt hot, shaky, itchy on trunk and inner arms, nauseated an hour after administration.
All over muscle aches. Back pain located in lumbar region. Common cold symptoms such as stuffy nose, headache and fatigue. Drowsiness. Unclear thoughts.
Red, raised, itchy, warm area on arm, approximately 7? long  x 4? wide.  Condition appeared 2 days after vaccine received. Condition persisted for about  1 week, as described above. However, the skin in that area continues to itch, sting, and exhibit a different texture one month later, even after redness has subsided.
One hour after immunization, a rash and redness down back appeared.  She was given 50mg Benadryl and watched for another 30 minutes.  No other reaction occurred
Dystonic reaction treated with IV Benadryl then PO Valium in ER. Second ER visit 2/18/07 treated with Cogentin. Symptoms resolved after 12 days. 03/21/07-records received from ER facility for services provided on 3/18 and  3/21/07-DX:Dystonic reaction.  HX: involuntary spasms, seen in ER day prior. DX at that time dystonic reaction. treated with benadryl and valium. Had 5 doses of valium, now spasms with eyes rolling.  Current medications Lexapro.  Allergy: Phenergan (dystonic and psychotic reaction). Neuro exam normal. Spasms observed, eye rolling. DC with cogentin. 2/21/07 seen in ER DX: dystonic medication versus vaccine reaction. Neuro exam normal. No spasm observed. Schedule MRI.  04/11/07-records received from ER for DOS 2/16/07-placed on Lexapro 2 weeks prior to ER visit. C/O erratic jerking moments. Upper body and shoulders. Voluntary control of arms and shoulders, legs and neck intact. HX depression. Additional findings: Facial and left arm muscles contracting spontaneously. DX: Dystonic drug reaction. Discontinue Lexapro.
06/22/22 1425 administered Menactra to LD while patient was seated. Patient stated, "That wasn't bad." Patient immediately lost consciousness and fell to left side towards mother while this nurse was washing hands. This nurse ran to patient. Patient had 10 second seizure like activity before returning to baseline. Oriented to person, place, and time. Denied vision changes, vertigo, and pain. BP 98/68 with pulse 60. Monitored patient for 10 minutes. Mother refused EMS, but agreed to take patient to ED. Assisted patient to wheelchair and then to car.
I have extremely heavy flow of menstruation even though I am on the pill.  Very extreme for days .
My tongue started tingling on the opposite side from where I got my shot. It would tingle for around an hour and then would stop for about two hours.; This is a spontaneous report from a non-contactable consumer (patient). A 51-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient reported that her tongue started tingling on the opposite side from where she got her shot. It would tingle for around an hour and then would stop for about two hours. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Chills, fatigue, headache, nausea lasting 5-6 hours. Localized reaction circular, well demarcated erythematous, puritic hematoma 2.5 inches in diameter at injection site
His leg burns and feels like a burn.; affected her to make her neck and the ball she had in her neck and clavicle; whole body hurts; she feels worse every day,; hip hurts; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (His leg burns and feels like a burn.), NECK PAIN (affected her to make her neck and the ball she had in her neck and clavicle), PAIN (whole body hurts), MALAISE (she feels worse every day,) and ARTHRALGIA (hip hurts) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 038K20A) for COVID-19 vaccination.     The patient's past medical history included Fall.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (His leg burns and feels like a burn.), NECK PAIN (affected her to make her neck and the ball she had in her neck and clavicle), PAIN (whole body hurts), MALAISE (she feels worse every day,) and ARTHRALGIA (hip hurts). At the time of the report, BURNING SENSATION (His leg burns and feels like a burn.), NECK PAIN (affected her to make her neck and the ball she had in her neck and clavicle), PAIN (whole body hurts), MALAISE (she feels worse every day,) and ARTHRALGIA (hip hurts) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment medication included the vitamins and stopped taking anti-inflammatory drugs.
Initial and follow-up information has been received from a receptionist in a physician's office and a licensed practical nurse (LPN) concerning a female (initially reported as 3 females, later confirmed to be only 1) between the ages of 11 and 13 (initially reported as "teenager age") who was vaccinated with a dose of GARDASIL. Concomitant therapy included "2 other shots the same day" (therapy unspecified). Subsequently the patient fainted when administered the first dose or shortly after and experienced pain at the injection site. Subsequently, the patient recovered later that afternoon. The LPN discussed this with the physician and neither one felt that the faint had anything to do with the GARDASIL. Additional information has been requested.
Left side stroke;severe headache;blindness;treatment was TPA;no significant finds in any test;currently being treated as a cardiac patient
muscle aches,; severe back ache; soreness in arm; fatigue; This is a spontaneous report from a contactable consumer.A 68-year-old female patient (non-pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN60205), via an unspecified route of administration on arm left on 25Feb2021 10:00 AM at single dose for COVID-19 immunization. The patient medical history included scoliosis, high cholesterol and has allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines in 4 weeks. The patients concomitant medications included Preservision Areds 2, Atorvastatin 10 mg, Vitamins. On 25Feb2021, the patient experienced soreness in arm and fatigue same night as vaccine. Next morning muscle aches, severe back ache, fatigue - arm had improved.. The events resulted in doctor or other healthcare professional office/clinic visit. The patient treatment included chiropractic adjustment. It was unknown if the patient recovered from the events..  No follow-up attempts are possible. No further information is expected.
A few days after the vaccine I woke up with severe excruciating back pain which lasted about 3 days. I used a salon pas (heating pad) to help with the discomfort and after about a week all symptoms subsided.
Information has been received concerning a female patient, with no allergies who on 01/11/2003 was vaccinated with a dose of pneumococcal vaccine 23 polyvalent (Lot # 644219/1079M).  Subsequently the patient developed swelling "up under the arm, not at the injection site."  Unspecified medical attention was sought.  Follow up information was received from a physician concerning a 82 year old male patient (previously reported as female) who on 01/09/2003 (previously reported as 01/11/2003 was vaccinated with a second dose of pneumococcal vaccine 23 polyvalent (Lot # 644219/1079M) into the left arm.  Concomitant medication includes rofecoxib (MSD).  Subsequently, on 01/10/2003, the patient developed erythema on the side of the arm opposite of the injection site, 3 inches by 3 inches.  It was noted that the patient required a doctor visit.  It was reported that the patient recovered.  It was noted that a female (previously reported as  male) patient from the same source had a similar experience (WAES # 0301USA00989).  Additional information is not expected.
This spontaneous report was received from a registered nurse referring to a patient of currently 61 years of age and unspecified gender. The patient's pertinent medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated with improperly stored dose of ZOSTAVAX, lot # L035283, expiry date: 15-DEC-2016 (dose, route of administration and anatomical location not reported). The doses of ZOSTAVAX underwent temperature excursion: 14.7F for 2 hours and 15 minutes. There were no previous temperature excursions. No symptoms were reported. No product quality complaint (PQC) was involved. No further information was provided. This is one of several reports from the same reporter. Additional information has been requested.
This spontaneous report was received from a licensed practical nurse and refers to a 16 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 31-AUG-2015, the patient was vaccinated with a dose of GARDASIL (lot # L010596, dose and route were not provided) that had experienced an excursion. No adverse reaction was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Urticaria starting the day of vaccine, several hrs after vaccine given. No breathing difficulties. Pt was treated with Benadryl.
Patient developed arm pain where injection was given one day after receiving. Area continues to be sore in the (L) deltoid, and increased pain with extension.
SARS-Covid -2 Ab IGG and it turned negative; This is a spontaneous report from a contactable physician (patient). This female patient of unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) via an unspecified route of administration on 11Jan2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 for COVID-19 immunization on an unspecified date. The patient reported completing her vaccination with the two doses on 11Jan (2021). She had blood drawn for annual exam and requested to add SARS-COVID-2 "Ab IGG" and it turned negative. She further reported understanding that she had not developed antibodies. The physician inquired if she should repeat the test, how she should interpret the results, and if there were any recommendations or suggestions as she was concerned she may be vulnerable. Laboratory tests and procedures on an unspecified date indicated SARS-COVID -2 "Ab IGG" negative. The clinical outcome of SARS-COVID-2 "Ab IGG" and it turned negative was unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Diffuse rash on body present 12 days after vaccination. Possible low grade temp as well.
Rash began close to site of injection 5 minutes post injection (09:35 am). Redness began to spread over arm. BENADRYL given PO 12.5 mg at 09:35. Another 37.5 mg PO BENADRYL given at 10:08. Patient being monitored post-BENADRYL. Vital signs stable. Patient given albuterol treatment 5mg for asthma exacerbation. Oxygen saturation 99%, heart rate 95 bpm, 24 respirations per minute. Post treatment: Oxygen saturation 100%, respirations 24, heart rate 71 bpm. Patient complaining of "itchy" throat and voice change noted by MD at 10:35 am. Epinephrine 1:1000 given - 0.5mL IM given at 10:40 am. Patient escorted to ER for continued monitoring and treatment. Oxygen saturation 100%, BP 137/81, 87 heart rate, 98.0 temp before epi given. After epi given, oxygen saturations monitored en route to ER. Oxygen saturation remained 100% and heart rate remained consistent between 70-80 bpm.
Pt to ED 11/13 for aphasia. Pt COVID+ 11/13, A&OX4, denies pain or any discomfort. 11/14 Pt complaints of headache earlier in shift but no longer. VSS. Pleasant mood. States that she feels better than when she first came in. Pt discharged 11/14.
Nausea; Vomiting; Cold shakes; Entire body aches; 101.6 temp; This is a spontaneous report received from a contactable consumer, the patient. A 44-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: EN6208) via an unspecified route of administration in left arm on 17Mar2021 at 09:00 am (age at vaccination 44-year-old), as single dose for COVID-19 vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: En 6202) via an unspecified route of administration in left arm on 20210225 at 11:30 am as single dose for COVID-19 vaccination. Medical history included high cholesterol and penicillin allergy. Patient was not diagnosed with COVID-19 prior to vaccination and since the vaccination, was not tested for COVID-19. The patient experienced Nausea, vomiting, cold shakes, entire body aches and temperature of 101.6 (units unspecified) on 17Mar2017 at 22:00. The patient did not receive any treatment for the reporting events. The clinical outcome of nausea, vomiting, chills, general body pain and high temperature was not resolved.   No follow-up attempts are possible. No further information is expected
Deathly ill from the Moderna vaccine 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Deathly ill from the Moderna vaccine 1st dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Deathly ill from the Moderna vaccine 1st dose). At the time of the report, ILLNESS (Deathly ill from the Moderna vaccine 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Noted hives abdomen and legs, 3-4mm size, many in number. Spot on L arm, 3-4" across, red raised in the vicinity of previous injection site. Now, hives continue though, number less. Arm is only red, maybe 3" across at injection site.
Fever, chills, pain in stomach and headaches. Symptoms lasted 2 days. No treatment needed. Felt fine afterwards.
Shot at 10:30, felt fine until about 4:30-5 started getting body aches, muscles sore joints hurt, 7:30-8 high fever, freezing in 80 degrees. Headache, nausea, restless leg syndrome acted up
inc temp few hrs p/vax;grandma tonic-clonic sz;2nd sz 830AM, 1130AM 4NOV95
Couldn't smell the Vapor Rub; I am very nasally and it's all up in my head; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NASAL DISORDER (I am very nasally and it's all up in my head) and ANOSMIA (Couldn't smell the Vapor Rub) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced NASAL DISORDER (I am very nasally and it's all up in my head). On 09-Mar-2021, the patient experienced ANOSMIA (Couldn't smell the Vapor Rub). At the time of the report, NASAL DISORDER (I am very nasally and it's all up in my head) and ANOSMIA (Couldn't smell the Vapor Rub) outcome was unknown.            Treatment medications included Z-pack and Vapor Rub
felt numbness at the injection site; moderate upper arm pain from just below the injection site to all the way up the left side of my neck to the jaw line; moderate upper arm pain from just below the injection site to all the way up the left side of my neck to the jaw line; moderate upper arm pain from just below the injection site to all the way up the left side of my neck to the jaw line; Throughout the day (Dated) it became increasingly difficult to turn my head in any direction and is very painful to move it to the left; This is a spontaneous report from a contactable other healthcare professional (patient).  A 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: unknown), via an unspecified route of administration from 06Jan2021 14:15 (reported as "02:15 PM") at single dose on the left arm as COVID vaccine. The COVID-19 vaccine was administered in a workplace clinic. Medical history included gastrooesophageal reflux disease (GERD), Acid Reflux Disease, Pseudo Tumor and known allergies reported as "Known allergies: Sulfate Drug, Pertussis".  The patient's concomitant medications were not reported.  Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications received within 2 weeks of vaccination. The patient reported that directly after the shot, she felt numbness at the injection site and stated "I realize this is normal and the shot was given properly and painlessly in the upper left arm) at approximately 2 am (12 hours after receiving the vaccine)". Patient woke up with moderate upper arm pain from just below the injection site to all the way up the left side of my neck to the jaw line. Throughout the day on 07Jan2021, it became increasingly difficult to turn her head in any direction and was very painful to move it to the left. The events occurred on 07Jan2021 -2:00 AM. Events were assessed as non-serious. No treatment was received for the events. No Covid prior vaccination. The patient was not tested for COVID after/post vaccination. Outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Patient waited the 15 minutes in front of the pharmacy and then started shopping in the store and passed out on one aisle in the store. I was called to look at patient and they had already placed him in a chair and he was alert but weak and was able to answer questions coherently. His son that was with him call EMS to come.  I called the son later in the day to see how everything was going and the son said that EMS told him all vitals were normal and he did not go with them.  He then told me that his dad and him were having dinner at the time I called and that he felt fine. He also said his dad did not have breakfast that morning which could have contributed to it since he had T2DM.
Patient reported to front desk staff that she was "feeling funny". Nursing staff overheard this conversation and immediately  brought patient into an exam room for evaluation.  Patient has many allergies and history of anaphylaxis. Patient carries her own Benadryl and EpiPen. Patient reported tongue swelling, slurred speech and dizziness. Dr. was asked to evaluate patient and instructed her to take the Benadryl. Patient took the Benadryl that she had brought along to the appointment. There was a nurse in the room to observe the patient and the patient was not left alone at any point in the visit. EMS was called and patient was transported to the emergency department for further evaluation. Patient reported that her symptoms were improving prior to going with EMS to the ED.
This spontaneous report as received from a medical assistant refers to a 22 year old female patient. Patient's medical history, concurrent conditions and drug reactions/allergies were not reported. The patient received her first dose of VAQTA on 21-NOV-2011. On 14-JUL-2016, the patient was vaccinated with a pediatric dose of VAQTA as her second dose, (lot #, expiration date, dose and route of administration were not reported). Patient's concomitant medication was not provided. No adverse symptoms were reported. A product quality complaint was not involved. Additional information is not expected because the reporter did not want to be contacted.
pain on hips really bad; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a sponsored program.  A 77 year-old female patient received bnt162b2 (BNT162B2), administration date Dec2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ENBREL taken for rheumatoid arthritis, start date: 07Aug2021. Past drug history included: Enbrel for Rheumatoid arthritis, reaction(s): "Device issue", notes: Enbrel (Unit=Cartridge). Vaccination history included: Covid-19 vaccine (Dose 1, MANUFACTURER UNKNOWN), for COVID-19 immunisation; Covid-19 vaccine (Dose 2, MANUFACTURER UNKNOWN), for COVID-19 immunisation. The following information was reported: ARTHRALGIA (non-serious), outcome "unknown", described as "pain on hips really bad". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Hives rash started on 7/12/17 with burning in hands and feet - home treatment with calamine/BENADRYL X 2 days then ER.